Search

everythinglearnresearchcommunity

for

Search:↓

The document explains different hair loss types and treatments, emphasizing diagnosis through examination and tests, and specific treatments for each condition.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Ruxolitinib treatment may cause eyelash growth.

Most pregnant women experience skin changes, mainly increased pigmentation, and some develop pregnancy-related skin conditions and infections.

Submental tissue is good for repairing mouth area skin with minimal scarring and good cosmetic results.

Hair loss has many causes and treatments, and losing some hair daily is normal; proper diagnosis is key, and minoxidil can help treat it.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Most HIV patients develop skin symptoms that can indicate the stage of their disease.

Dr. Vera H. Price's 1979 work emphasizes the importance of accurate diagnosis and personalized treatment for hair loss.

During the COVID-19 pandemic in Turkey, the most common skin problem for both kids and adults was acne.

Some drugs can cause skin reactions, which may improve when the drug is stopped, and rapid diagnosis and stopping the drug is crucial.

Some skin medications are safe for pregnant women, but others pose risks or should not be used.

The document concludes that periocular hair disorders have various causes and treatments, and proper evaluation by specialists is important for management and prognosis.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

The review shows how to properly diagnose and treat the loss of eyebrow and eyelash hair.

A wearable cap-like device using light therapy reduced scalp skin lesions by 71% and was painless.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

A patient's skin eruption was caused by the cancer drug cyclophosphamide and improved after stopping the drug.

Treating both the mind and skin together, especially by managing stress, can greatly improve outcomes for skin disorders linked to psychological issues.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

Up to 50% of scalp hair can be lost before it appears thin, and treatment is only needed for hair loss caused by diseases or deficiencies.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Women with skin conditions who have body image concerns often experience mental health issues and a lower quality of life.

Compounds from certain trees used by First Nations people show potential for treating skin conditions and promoting hair growth, but more research is needed to confirm their safety and effectiveness.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

The SARS-CoV-2 vaccine may be linked to triggering autoimmune conditions like Alopecia Areata.

Focus on common skin diseases like eczema and infections to improve diagnosis and management.

A man developed an allergic skin reaction to a rosacea treatment and improved after stopping the medication and receiving allergy-specific care.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.